Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Eight Roads, F-Prime Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
A climate technology company reducing global plastic dependency by scaling biomaterial adoption.
Sustanix develops novel biomolecules for advanced biomaterials, takes it from lab to industrial scale.
TômTex is a materials innovation company that is creating a new class of next-gen biomaterials.
Eterna RegenerativesVenture round $4M · this month • 11-50 employees
Eterna Regeneratives develops regenerative biomaterials for mineralisation and tissue regeneration, with initial applications in oral…
PondaEquity Crowdfunding $1.7M · 1 mo ago • 51-200 employees
Ponda is a biomaterials company developing novel textiles from truly regenerative fibres. We connect the regeneration of some of our most…
SQIMVenture round $11.9M · 2 yr ago
SQIM - The Material Innovation company biofabricating biomaterials grown from mycelium through fungal fermentation, valorising waste and…

Overview

司由知名留美科学家舒晓正博士于2008年4月28日成立,是一家以自交联和生物模拟材料(Advanced Self-Crosslinked & Biomimetic Biomaterials)为技术平台,深耕临床医学和生物医药领域,具备自主研发能力的高新技术企业。致力于成为国内外新型创伤修复生物医用材料的领跑者,主营业务是新型生物医用材料及药物缓释剂的产品研发、生产及销售,以解决五官科、妇产科、普外科等临床科室的疑难需求。心怀美丽愿景和崇高使命:让创伤组织重回自然焕发新生。百瑞吉先后开发了一系列针对五官科、妇产科等所需的术后功能性愈合材料,并成功进入美、德、英、法、意等发达国家的医药市场。.